Erythrocyte oxidative damage in chronic fatigue syndrome.
Richards, Ross S, Wang, Lexin, Jelinek, Herbert · Archives of medical research · 2007 · DOI
Quick Summary
This study compared blood cells from 31 ME/CFS patients and 41 healthy people, looking for signs of damage from harmful molecules called free radicals. Researchers reported observing higher levels of oxidative stress markers in ME/CFS patients' red blood cells, along with more abnormally shaped cells, but these are early findings in a small group and do not yet explain how or why this happens in ME/CFS.
Why It Matters
Red blood cells are fundamental to oxygen transport, and abnormalities in their chemistry or shape could theoretically contribute to symptoms in ME/CFS. This study provides preliminary quantitative evidence that oxidative stress markers are altered in ME/CFS erythrocytes compared to healthy controls, which may prompt further investigation into whether free radical damage plays a role in ME/CFS pathophysiology.
Observed Findings
Significantly elevated methemoglobin (metHb) levels were observed in ME/CFS patients compared to controls (p < 0.005).
Significantly elevated malondialdehyde (MDA) levels were observed in ME/CFS patients compared to controls (p < 0.01).
Significantly elevated 2,3-diphosphoglyceric acid (2,3-DPG) levels were observed in ME/CFS patients compared to controls (p < 0.05).
A higher prevalence of stomatocytes (cup-shaped erythrocytes) was observed in ME/CFS patients compared to controls (p < 0.005).
These markers were associated with abnormal red blood cell morphology in the ME/CFS group.
Inferred Conclusions
The authors interpreted the elevated oxidative stress markers as evidence of increased free radical activity in ME/CFS erythrocytes.
The authors proposed a mechanistic link between redox metabolism and erythrocyte shape, with the hypothesis that antioxidant activity is associated with stomatocyte formation.
The authors suggested these findings support the hypothesis that free radicals may play a role in ME/CFS pathogenesis, based on consistency with prior smaller studies.
Remaining Questions
Do oxidative stress markers in erythrocytes correlate with ME/CFS severity or specific symptom profiles?
What This Study Does Not Prove
This study does not establish that oxidative damage causes ME/CFS or its symptoms; it documents an association in a single cross-sectional comparison. It does not identify whether observed oxidative markers are a primary driver of disease, a secondary consequence, or incidental. The small sample size and unknown case definition quality limit generalisability beyond this cohort.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.